| P50 | author | James A Pearson | Q57339799 |
| | F. Susan Wong | Q63411298 |
| | Elke Gülden | Q85326434 |
| P2093 | author name string | Jian Peng | |
| | Zhiguang Zhou | |
| | Li Wen | |
| | Ningwen Tai | |
| | Monika Majewska-Szczepanik | |
| | Chen Chao | |
| P2860 | cites work | The role of the intestinal microbiota in type 1 diabetes mellitus | Q35884681 |
| | Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans | Q36004640 |
| | NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets. | Q36056835 |
| | Differential outcome of TRIF-mediated signaling in TLR4 and TLR3 induced DC maturation | Q36300342 |
| | Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes | Q36323689 |
| | Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion | Q36945852 |
| | TLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice. | Q37210998 |
| | Microbial antigen mimics activate diabetogenic CD8 T cells in NOD mice | Q37272130 |
| | Mucosal Prevalence and Interactions with the Epithelium Indicate Commensalism of Sutterella spp. | Q37366316 |
| | Effects of the gut microbiota on obesity and glucose homeostasis | Q37847381 |
| | Changes of regulatory T cells, transforming growth factor-beta and interleukin-10 in patients with type 1 diabetes mellitus: A systematic review and meta-analysis | Q38920811 |
| | Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection | Q39097028 |
| | Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study | Q40088313 |
| | The intestinal proteome of diabetic and control children is enriched with different microbial and host proteins | Q40304529 |
| | TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes | Q41936111 |
| | Dual signaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic cell maturation | Q41937286 |
| | T-lymphocyte clone specific for pancreatic islet antigen | Q46335815 |
| | Compromised gut microbiota networks in children with anti-islet cell autoimmunity | Q46922105 |
| | Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase | Q46972336 |
| | Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways | Q48219736 |
| | CD69 modulates sphingosine-1-phosphate-induced migration of skin dendritic cells | Q58063831 |
| | The Role of Toll-Like Receptors 3 and 9 in the Development of Autoimmune Diabetes in NOD Mice | Q59276520 |
| | Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes | Q80813712 |
| | Toward defining the autoimmune microbiome for type 1 diabetes | Q24629032 |
| | Innate immunity and intestinal microbiota in the development of Type 1 diabetes | Q24647312 |
| | The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors | Q27860900 |
| | Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway | Q28592087 |
| | Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences | Q29615050 |
| | UPARSE: highly accurate OTU sequences from microbial amplicon reads | Q29616627 |
| | Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice | Q30644510 |
| | Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis | Q33258217 |
| | Molecular inventory of faecal microflora in patients with Crohn's disease | Q33497564 |
| | Role of the microbiota in immunity and inflammation | Q33752553 |
| | Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation | Q33970555 |
| | Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes | Q34063601 |
| | The microbiota in adaptive immune homeostasis and disease | Q34533142 |
| | Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study | Q34596660 |
| | Toll-like receptor 3 is critical for coxsackievirus B4-induced type 1 diabetes in female NOD mice. | Q34982303 |
| | Toll-like receptor 4 deficiency accelerates the development of insulin-deficient diabetes in non-obese diabetic mice | Q35005601 |
| | Long term effect of gut microbiota transfer on diabetes development | Q35157830 |
| | Ablation of tumor necrosis factor is associated with decreased inflammation and alterations of the microbiota in a mouse model of inflammatory bowel disease. | Q35182119 |
| | Aberrant gut microbiota composition at the onset of type 1 diabetes in young children | Q35188386 |
| | The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes | Q35557877 |
| | The gut microbiota and Type 1 Diabetes. | Q35655645 |
| | Microbiota regulates type 1 diabetes through Toll-like receptors | Q35718048 |
| P921 | main subject | type-1 diabetes | Q124407 |
| | dendritic cell | Q506253 |
| P304 | page(s) | 57-65 | |
| P577 | publication date | 2018-06-28 | |
| P1433 | published in | Journal of Autoimmunity | Q15716783 |
| P1476 | title | TRIF deficiency protects non-obese diabetic mice from type 1 diabetes by modulating the gut microbiota and dendritic cells | |
| P478 | volume | 93 | |